This Investment Digest is summarizing key players and observations in the private equity and venture capital ecosystem, focusing on the longevity industry. Here we have summarized information about key industry trends, more than 1700 promising longevity companies, 50 leading investors in this sector, and more than 50 longevity-focused publicly traded corporations, outlining major investment rounds and relevant R&D trends illustrating the industry traction and readiness of institutional investors (big pharma/biotech) to potentially acquire most successful AgeTech and Longevity Biomedicine startups.